Ultralife Corporation Reports Q2 2026 Revenue Decline but Increased Profitability

Ultralife Corporation reported its financial results for the second quarter and first half of 2026, revealing a slight decline in revenues and a notable increase in profitability. For the three-month period ending June 30, 2026, the company generated revenues of $47.9 million, a decrease of 1.3% from $48.6 million in the same period last year. The decline was attributed to a 4.7% drop in commercial sales, which was partially offset by a 5.0% increase in government and defense sales. Gross profit for the quarter rose to $13.9 million, or 28.9% of revenue, compared to $11.6 million, or 23.9% of revenue, in the prior year, primarily due to a favorable sales mix and a net refund of IEEPA tariffs.

In the first half of 2026, Ultralife's revenues totaled $95.4 million, down 3.9% from $99.3 million in the same period of 2025. The decrease was driven by a 5.1% decline in commercial sales and a 1.8% drop in government and defense sales. Despite the revenue decline, net income attributable to Ultralife increased to $2.5 million, or $0.15 per share, for the second quarter, compared to $879,000, or $0.05 per share, in the prior year. For the first half, net income was $2.1 million, or $0.13 per share, down from $2.7 million, or $0.17 per share, in 2025.

Operationally, Ultralife has focused on enhancing its product offerings and investing in new product development, which contributed to a 39.1% increase in research and development expenses for the second quarter. The company also reported a total backlog of $117.5 million, the highest in its history, indicating strong future demand. The Battery & Energy Products segment saw a revenue decline of 3.7%, while the Communications Systems segment experienced a significant revenue increase of 39.3% due to the timing of orders.

The company continues to navigate challenges such as supply chain disruptions and fluctuating market conditions. Ultralife's management remains optimistic about future growth, emphasizing ongoing efforts to improve operational efficiency and advance vertical integration in its oil and gas segment. The company expects to generate positive operating cash flow and maintain sufficient liquidity to meet its funding requirements, supported by its available borrowings under the Revolving Credit Facility. As of June 30, 2026, Ultralife had $6.7 million in cash and was in compliance with its debt covenants.